Company Filing History:
Years Active: 2000
Title: Helmut H Schneider: Innovator in Bivalent Molecules
Introduction
Helmut H Schneider is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biochemistry, particularly in the development of bivalent molecules. His work focuses on the activation of erythropoietin receptors, which has implications for drug discovery and treatment of related disorders.
Latest Patents
Helmut H Schneider holds a patent for bivalent molecules that form an activating complex with antibodies. This patent also includes bivalent molecules that activate erythropoietins and induce the proliferation or differentiation of erythroid progenitor cells. The methods provided in this patent are crucial for drug discovery, diagnosis, and treatment of disorders associated with erythropoietin receptor activation. He has 1 patent to his name.
Career Highlights
Schneider is currently associated with Axys Pharmaceuticals, Inc., where he continues to innovate in the field of biochemistry. His work has been instrumental in advancing the understanding of erythropoietin receptors and their potential therapeutic applications.
Collaborations
Some of his notable coworkers include Warak Lee Chaovapong and Lutz B Giebel. Their collaborative efforts contribute to the ongoing research and development in the field.
Conclusion
Helmut H Schneider's contributions to the field of biochemistry, particularly through his patent on bivalent molecules, highlight his role as an innovator. His work at Axys Pharmaceuticals, Inc. continues to pave the way for advancements in drug discovery and treatment methodologies.